Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
about
Glycoproteomic and glycomic databasesExploring site-specific N-glycosylation microheterogeneity of haptoglobin using glycopeptide CID tandem mass spectra and glycan database searchAnalysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologiesSolid phase extraction of N-linked glycopeptides using hydrazide tipSite-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4.Quantification of fucosylated hemopexin and complement factor H in plasma of patients with liver diseaseQuantitative analysis of immunoglobulin subclasses and subclass specific glycosylation by LC-MS-MRM in liver disease.Applications of Multiple Reaction Monitoring to Clinical Glycomics.Site-specific analysis of changes in the glycosylation of proteins in liver cirrhosis using data-independent workflow with soft fragmentation.A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum GlycoproteinsAnalysis of Urinary Prostate-Specific Antigen Glycoforms in Samples of Prostate Cancer and Benign Prostate HyperplasiaGlycoprotein disease markers and single protein-omicsSite-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinomaGlycomics and glycoproteomics of membrane proteins and cell-surface receptors: Present trends and future opportunities.Increased sialylation of site specific O-glycoforms of hemopexin in liver disease.Absolute quantitation of immunoglobulin G and its glycoforms using multiple reaction monitoring.The challenge and promise of glycomics.A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.Label-free absolute quantitation of oligosaccharides using multiple reaction monitoring.Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery.Quantitative mass spectrometric analysis of glycoproteins combined with enrichment methods.Targeted methods for quantitative analysis of protein glycosylation.Glycosylation and liver cancer.Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.Algorithms and design strategies towards automated glycoproteomics analysis.Insights on N-glycosylation of human haptoglobin and its association with cancers.A case for protein-level and site-level specificity in glycoproteomic studies of disease.Glycans and glycoproteins as specific biomarkers for cancer.Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.Identification of IgM as a contaminant in lectin-FLISA assays for HCC detection.Protein and site specificity of fucosylation in liver-secreted glycoproteins.LC-MS/MS quantitation of esophagus disease blood serum glycoproteins by enrichment with hydrazide chemistry and lectin affinity chromatography.The Use of Multiple Reaction Monitoring on QQQ-MS for the Analysis of Protein- and Site-Specific Glycosylation Patterns in Serum.Glycoproteins Enrichment and LC-MS/MS Glycoproteomics in Central Nervous System Applications.
P2860
Q21245406-D40E60A4-1C44-45F1-929A-0988D714983FQ28680669-DA542D00-8F8F-4964-8BCF-29C01E4ACE79Q33762901-31E0E839-B3F9-4379-9019-30D4B2FB3E28Q33849938-D8C4EF9F-FDAA-4E8B-AE98-A11397BB8782Q33855700-084C3301-3FA9-4579-B548-22BAB62ED73BQ34464343-34941284-8005-49BE-A399-79948CA6D2E7Q35085189-39FBC6C9-FD9A-443F-AC77-2628EF67316EQ35447868-F0D50ED7-AF26-4516-AC96-DBAD7F28725EQ36185188-9016ACE3-71AE-4FC0-B7B0-E4296BF05C0AQ36348802-E9196237-97CA-47CC-B427-C3AE6257EABFQ36737765-C4E3AAEB-4A43-4A22-BB08-51F173D35FDFQ36742398-1942FC9B-3547-4387-B6E3-04DFC8BE4684Q36832489-173A5A95-2424-4AA4-B145-70121EA0694BQ36957711-45691203-2D77-42BC-9F17-C64BA8BA3B93Q37278723-4764AB5B-52D3-477A-AE65-77E69C1831ACQ37378334-2E1362DF-6F6F-470D-8149-8872A2C835C6Q37638949-DD970C63-E9E3-4A23-97E2-5EAA31542E88Q37651691-CA199DF5-C220-426C-95BB-9CD436678B30Q37696921-5CD60C15-A0EE-4DF3-96A4-ACB77CC9436BQ38215756-158A7CD2-CBBD-4E46-B2EA-B06D6801A47BQ38217009-3D30259B-56D4-4D3C-B9E0-ADF354866522Q38293204-37F990B6-818B-4031-B4F6-41230959F76DQ38366329-C72DA168-FBA5-4BBF-B69D-F9372B1A5BA3Q38604366-9760989C-F2BA-48A6-BC24-60369C38B725Q38686132-252EB8F6-0FE1-43FC-B998-DB5F380BFB13Q38731700-88B4A051-F99A-42D0-AC4B-18A06FBD3CC9Q38786094-F6AA67E8-62C3-4E6A-B0DB-4417443A5C42Q38945184-282E2808-2BA4-487F-B71D-DE6749807E8BQ39373031-94205D21-2152-4181-A41F-DADF02A3CD61Q41479549-88E8109A-78BC-43E3-82B9-C742286BF1EBQ42185516-BD092EE4-22EB-432D-B681-212557ECA0F4Q42998397-8929DC03-807B-4153-B556-A39F1F2AA8E5Q43677119-8A81B11D-BADE-4910-8AC7-50000D313033Q47153267-B50BBA40-87DA-48B6-A847-A5BF647B4F95
P2860
Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Quantitative liquid chromatogr ...... haptoglobin in liver disease.
@en
type
label
Quantitative liquid chromatogr ...... haptoglobin in liver disease.
@en
prefLabel
Quantitative liquid chromatogr ...... haptoglobin in liver disease.
@en
P2093
P2860
P356
P1476
Quantitative liquid chromatogr ...... haptoglobin in liver disease.
@en
P2093
Kepher Makambi
Miloslav Sanda
Petr Pompach
Radoslav Goldman
Zuzana Brnakova
P2860
P304
P356
10.1074/MCP.M112.023325
P577
2013-02-06T00:00:00Z